IL4 and neoplasm: This is specific to IL-13 as mice lacking IL-4 were significantly less susceptible to tumour development following DMBA–TPA, suggesting that IL-4 may drive inflammation in this model, whereas IL-13 works differently (Fig. 4g,h).